Why the study?
Does acetazolamide improve symptoms in patients with SCN4A-associated hypokalemic periodic paralysis?
Does acetazolamide improve symptoms in patients with SCN4A-associated hypokalemic periodic paralysis?
The paper suggests that patients with SCN4A-associated hypokalemic periodic paralysis may benefit from a trial of acetazolamide.
Authors
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for acetazolamide in SCN4A hypokalemic periodic paralysis; prospective trials needed before practice change.
Venance et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: